Your session is about to expire
← Back to Search
Recast Therapy vs. Book Reading for Developmental Language Disorder
N/A
Recruiting
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Primarily English speaking as documented by 20% or less exposure to another language, per parent report on the MAPLE
Diagnosed with DLD as documented by standard score below 85 on the Diagnostic Evaluation of Language Variation - Norm Referenced (DELV-NR) composite
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks post therapy ( ~12- 14 week mark in study timeline)
Awards & highlights
Study Summary
This trial will examine alternative methods of delivering treatment for Developmental Language Disorder (DLD) in order to identify implementation barriers and improve long-term outcomes.
Who is the study for?
This trial is for children aged 4-9 with Developmental Language Disorder (DLD), primarily English-speaking, and without autism or significant sensory-motor or psychiatric disorders. They must have a DLD diagnosis confirmed by specific language tests, hearing within the typical range, and caregivers willing to participate in training.Check my eligibility
What is being tested?
The study is testing two treatments for DLD: Recast Therapy where clinicians repeat children's phrases with grammatical improvements, and Syntax Stories which involves reading specially designed stories to improve grammar. The goal is to find feasible methods that can be used in typical service conditions.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves speech therapy techniques rather than medication. However, there may be varying levels of engagement or stress associated with the different treatment approaches.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I mainly speak English, with little exposure to other languages.
Select...
My language skills were scored below 85 on the DELV-NR test.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 2 weeks post therapy ( ~12- 14 week mark in study timeline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks post therapy ( ~12- 14 week mark in study timeline)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Accuracy on Elicited Production Probes
Change in Comprehension probes (Proportion Looking)
Estimated Dose Delivered
+1 moreSecondary outcome measures
Caregiver grammar knowledge
Change in Comprehension probes (Pointing)
Effortfulness of treatment
+3 moreTrial Design
4Treatment groups
Experimental Treatment
Group I: Recast Therapy Provided by a CaregiverExperimental Treatment1 Intervention
Caregivers will receive two training sessions on how to provide recast therapy and demonstrate their skill at providing recast therapy with support from the clinician. Caregivers will then provide recast therapy at a rate of 1 recast per minute to their children for a minimum of 16 hrs (960 exposures) scheduled at their own convenience.
Group II: Recast Therapy Provided By ClinicianExperimental Treatment1 Intervention
Children will be exposed to recasts at a rate of 1/minute. Treatment will be provided 2x/week for 8 weeks for a total of 16 visits (960 recasts). 2 additional weeks are allocated for make up visits. Treatment will be provided by a trained, certified, licensed Speech Language Pathologist (SLP).
Group III: Illustrated Syntax Stories Provided by a CaregiverExperimental Treatment1 Intervention
Caregivers will receive two training sessions on how to provide read illustrated syntax stories to their children and demonstrate their skill at reading these stories with support from the clinician. Caregivers will then read these stories to their children for a minimum of 32 book readings (960 exposures)
Group IV: Illustrated Syntax Stories Provided by ClinicianExperimental Treatment1 Intervention
Children will be listen to books that are specially scripted to promote the use of a particular syntax target. Treatment will be provided 2x/week for 8 weeks for a total of 16 visits (960 exposures), with 2 books read at each visit. 2 additional weeks are allocated for make up visits. Treatment will be provided by a trained, certified, licensed SLP.
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
154 Previous Clinical Trials
24,929 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
331 Previous Clinical Trials
178,013 Total Patients Enrolled
University of Maryland, College ParkOTHER
157 Previous Clinical Trials
45,955 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to undergo caregiver training if needed.My child is between 4 and 9 years old and has DLD.I mainly speak English, with little exposure to other languages.You can form basic sentences using a subject, verb, and object, and your average sentence length is at least 2.5 words per sentence.My language skills were scored below 85 on the DELV-NR test.You have normal hearing, as confirmed by a hearing test or assessment by a hearing professional.You must have difficulty understanding and using certain types of sentences in order to be eligible for the study.I am willing to complete questionnaires and interviews after the test.You do not have autism, as determined by scoring below 15 on the Social Communication Questionnaire.Your nonverbal IQ score should be at or above 35 on the Developmental Abilities Scale (DAS), matrices similarities subscale.
Research Study Groups:
This trial has the following groups:- Group 1: Recast Therapy Provided By Clinician
- Group 2: Illustrated Syntax Stories Provided by Clinician
- Group 3: Recast Therapy Provided by a Caregiver
- Group 4: Illustrated Syntax Stories Provided by a Caregiver
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger